SCHEMBL5374884

SCHEMBL5374884

CN(C)CCCNC(=O)c1ccc(N(C)C)cc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 9/20 0.73
HDAC10 Q969S8 8/20 0.73
HDAC6 Q9UBN7 8/20 0.73
HDAC8 Q9BY41 8/20 0.73
HDAC2 Q92769 7/20 0.73
HDAC3 O15379 5/20 0.73
HDAC4 P56524 4/20 0.73
HDAC7 Q8WUI4 4/20 0.73
HDAC11 Q96DB2 4/20 0.73
HDAC9 Q9UKV0 4/20 0.73
HDAC5 Q9UQL6 4/20 0.73
HPGD P15428 2/20 0.68
LTA4H P09960 1/20 0.63
KMT2A Q03164 1/20 0.60
SMN1; SMN2 Q16637 1/20 0.56
THRA P10827 1/20 0.56
THRB P10828 1/20 0.56
NAMPT P43490 1/20 0.55
KDM4E B2RXH2 3/20 0.54
ALDH1A1 P00352 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22112729 0.93 HDAC1 (0.64) HDAC1HDAC10HDAC6HDAC8HDAC2
SCHEMBL10020214 0.92 HPGD (0.79) HDAC1HDAC10HDAC6HDAC8HDAC2
SCHEMBL4171218 0.90 HDAC1 (0.68) HDAC1HDAC10HDAC6HDAC8HDAC2
SCHEMBL16128933 0.89 HDAC1 (0.70) HDAC1HDAC10HDAC6HDAC8HDAC2
SCHEMBL16128934 0.87 HDAC1 (0.73) HDAC1HDAC10HDAC6HDAC8HDAC2
SCHEMBL22015906 0.86 HDAC1 (0.71) HDAC1HDAC10HDAC6HDAC8HDAC2
SCHEMBL16128931 0.86 HDAC1 (0.76) HDAC1HDAC10HDAC6HDAC8HDAC2
SCHEMBL2120449 0.85 HPGD (0.70) HPGDKMT2ASMN1; SMN2THRATHRB
SCHEMBL8411545 0.85 HPGD (0.70) HDAC1HDAC10HDAC6HDAC8HDAC2
SCHEMBL17404990 0.85 HDAC1 (0.72) HDAC1HDAC10HDAC6HDAC8HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7205436-B2 Process for manufacture of quaternary ammonium tosylate salts of cinnamidoalkylamines and / or benzamidoalkylamines GALAXY SURFACTANTS LIMITED (IN) 2007-04-17 US disclosed
US-7147866-B2 UV-absorbing lipid vesicles GALAXY SURFACTANTS LIMITED (IN) 2006-12-12 US disclosed
US-7087692-B2 Salt and heat sensitive, substantive UV-absorbing polymers GALAXY SURFACTANTS LTD (IN) 2006-08-08 US disclosed
US-7045139-B2 Process for manufacture of quaternary ammonium tosylate salts of cinnamidoalkylamines and/or benzamidoalkylamines GALAXY SURFACTANTS LIMITED (IN) 2006-05-16 US disclosed
US-20060067893-A1 UV-absorbing lipid vesicles GALAXY SURFACTANTS LIMITED (IN) 2006-03-30 US disclosed
US-20050209327-A1 Novel process for manufacture of quaternary ammonium tosylate salts of cinnamidoalkylamines and / or benzamidoalkylamines GALAXY SURFACTANTS LTD. (IN) 2005-09-22 US disclosed
US-20050080135-A1 Novel process for manufacture of quaternary ammonium tosylate salts of cinnamidoalkylamines and/or benzamidoalkylamines GALAXY SURFACTANTS LTD. (IN) 2005-04-14 US disclosed
US-20040101498-A1 Salt and heat sensitive, substantive UV-absorbing polymers GALAXY SURFACTANTS LTD. (IN) 2004-05-27 US disclosed
EP-0738138-A1 QUATERNARY SALTS OF PARA-DIALKYLAMINO BENZAMIDE DERIVATIVES ISP Van Dyk Inc. (US) 1996-10-23 EP disclosed
EP-0738138-A4 QUATERNARY SALTS OF PARA-DIALKYLAMINO BENZAMIDE DERIVATIVES ISP VAN DYK INC (US) 1996-07-08 EP disclosed
US-5451394-A Quaternary salts of para-dialkylamino benzamide derivatives ISP VAN DYK INC. (US) 1995-09-19 US disclosed
US-5427773-A Sunscreen agents ISP VAN DYK INC. (US) 1995-06-27 US disclosed
WO-1995005797-A1 QUATERNARY SALTS OF PARA-DIALKYLAMINO BENZAMIDE DERIVATIVES ISP VAN DYK INC. (US) 1995-03-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040101498-A1 Salt and heat sensitive, substantive UV-absorbing polymers S100A10, SLC6A15, DAO HDAC1 1790/4885HDAC10 124/4885HDAC6 1371/4885
US-20050209327-A1 Novel process for manufacture of quaternary ammonium tosylate salts of cinnamidoalkylamines and / or benzamidoalkylamines NISCH, CUTA, PFAS HDAC1 1160/4885HDAC10 946/4885HDAC6 659/4885
US-20050080135-A1 Novel process for manufacture of quaternary ammonium tosylate salts of cinnamidoalkylamines and/or benzamidoalkylamines NISCH, CUTA, PFAS HDAC1 1160/4885HDAC10 946/4885HDAC6 659/4885
US-20060067893-A1 UV-absorbing lipid vesicles MBOAT1, ARCN1, NPC1L1 HDAC1 492/4885HDAC10 235/4885HDAC6 929/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.